Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Wills Robert James Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 4 Wills Robert James (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 25,000 options @ $0.3553, valued at $8.9k
06/09/2023 4 Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $3.86, valued at $115.8k
01/27/2023 4 Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $7.8, valued at $195k
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2022 4 Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $6.07, valued at $182.1k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2022 4 Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 67,000 options to buy @ $2.94, valued at $197k
07/29/2021 4 Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $5.54, valued at $166.2k
05/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/28/2021 4 Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 32,000 options to buy @ $5.78, valued at $185k
10/05/2020 4 Wills Robert James (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $7.1, valued at $213k
06/12/2020 4 Wills Robert James (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 15,000 options @ $2.94, valued at $44.1k
05/19/2020 4 Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 49,245 options to buy @ $4.05, valued at $199.4k
09/16/2019 4 Wills Robert James (Director) has filed a Form 4 on Oncternal Therapeutics, Inc.
Txns: Granted 30,000 options @ $5.76, valued at $172.8k
01/31/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/26/2018 4 Wills Robert James (Executive Chairman) has filed a Form 4 on GTX INC /DE/
Txns: Bought 5,000 shares @ $16.75, valued at $83.8k
01/26/2018 4 Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 16,000 options to buy @ $11.69, valued at $187k
01/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/01/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
10/17/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
09/09/2016 4 Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Bought 25,000 shares @ $2.4343, valued at $60.9k
06/30/2016 4 Wills Robert James (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.
Txns: Granted 9,000 options to buy @ $1.72, valued at $15.5k
06/20/2016 4 Wills Robert James (Executive Chairman) has filed a Form 4 on GTX INC /DE/
Txns: Bought 100,000 shares @ $0.6536, valued at $65.4k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy